Patient Recruitment White Paper & Articles

  1. Understanding The FDA's Push For More Representation In Clinical Trials 1/28/2025

    Take action to improve diversity in clinical trials by addressing underrepresentation and ensuring equitable access to medical interventions, as emphasized by the FDA’s new 2025 guidance.

  2. Why You Should Include SDOH In Clinical Trial Recruitment 1/28/2025

    Embrace a broader approach to diversity in clinical trials by addressing social determinants of health and designing inclusive studies that ensure equitable representation and access to all patients.

  3. Merits Of A Multifaceted Approach To Clinical Trial Recruitment 1/27/2025

    The best way to address clinical trial recruitment challenges is with a multifaceted approach that goes beyond traditional channels and ways of thinking.

  4. Trends In Clinical Trials In 2025: Navigating A Transformative Landscape 1/22/2025

    In 2025, it is likely the clinical trial landscape will be shaped by advancements in artificial intelligence (AI), evolving recruitment strategies, and a renewed focus on equitable access.

  5. Oncology Trials: Accuracy And Alleviating The Patient Screening Burden 1/17/2025

    Flatiron Health has unveiled an innovative service designed to enhance patient screening for clinical trials by integrating structured EHR data with machine learning and human analysis.

  6. Revolutionizing Clinical Trial Feasibility 1/13/2025

    Transform feasibility into a continuous, data-driven process, that helps sponsors streamline trial planning, maintain timelines, and deliver therapies to patients faster.

  7. Enrollment Benchmarking: Driving Predictability In Clinical Trial Timelines 1/13/2025

    Enrollment benchmarking, powered by advanced data solutions, has emerged as a critical tool in addressing patient enrollment challenges.

  8. Bringing Clinical Trials To Everyone's Backyard 1/10/2025

    Learn how bringing clinical trials to any community around the world is not only possible but also increases patient access and reach and improves recruitment and retention.

  9. Ensuring A Diverse Patient Population In Clinical Trials 12/13/2024

    In 2025, the FDA will require pharmaceutical companies to include diversity action plans (DAPs) for Phase II and pivotal studies.

  10. Overcoming Barriers To Clinical Trial Participation In Oncology 12/3/2024

    Oncology clinical trials face unique challenges in patient recruitment and retention due to barriers such as awareness, logistical constraints, and eligibility criteria.